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Abstract 
 
Brooks Scull:  Intestinal Regeneration After Irradiation:  Stem Cells and 
Sox9 
(Under the direction of P. Kay Lund) 
 
 
 Whole body irradiation is a useful challenge to study the response of intestinal 
epithelial stem cells (IESC) to genetic damage.  High dose irradiation causes complete 
loss of the proliferative zone within intestinal crypts excluding a few stem/multipotent 
cells that can regenerate the intestinal epithelial lining.  Whole body irradiation models 
using high dose irradiation are not ideal for studying the regenerative process due to 
poor animal survival.  Little is known about direct effects of irradiation on IESC due to 
lack of biomarkers.  This study developed a high dose abdominal irradiation model with 
increased survival allowing for analysis of regeneration to day 9 after irradiation and 
potentially longer.  The expression pattern of the putative IESC marker, Sox9, was 
evaluated and compared with proliferation markers.  We provide evidence that 
differential levels of Sox9 mark subpopulations of proliferating cells.  This model will be 
useful to evaluate therapies that increase IESC survival, proliferation and regeneration.  
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Chapter 1 
 
Introduction 
 
 
Intestinal Physiology 
The intestine is a tubular structure consisting of several layers including an outer 
serosa, longitudinal and circular smooth muscle, the submucosa and an inner mucosa.  
The mucosa comprises a single layer of epithelial cells facing the lumen, the underlying 
lamina propria which contains fibroblasts, myofibroblasts, blood vessels and resident 
immune cells, and the muscularis mucosa.  The epithelial lining functions in digestion 
and absorption of ingested nutrients and as a barrier protecting the underlying tissue 
from toxins, pathogens and commensal microbiota in the lumen.  The epithelial lining of 
the small intestine is organized into a crypt-villus axis with crypts representing 
proliferating cells and villi forming finger like projections into the lumen, which provide a 
larger surface area for digestion and absorption.  The colon, like the small intestine has 
crypts, but does not contain villi {{178 Wright,N.A. 2000}}.  In mammals, the epithelium 
of the small intestine and colon are in a constant state of renewal with turn over of the 
entire epithelium every 3-10 days depending on the region of the intestine and the 
species.  This renewal is driven by stem or multipotent cells thought to reside at the 
base of the crypts which maintain the continual process of epithelial renewal.  These 
stem cells are believed to remain at the base of the crypts and continually produce 
short-lived progenitor or transit amplifying cells that differentiate as they migrate up the 
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crypt axis and onto the villi or surface epithelium creating a spatially organized hierarchy 
of cells along the crypt-villus axis .  The intestine contains four differentiated cell 
lineages (Potten & Loeffler, 1990).  In the small intestine the lineages include 
enterocytes, goblet cells, and enteroendercrine cells, which migrate upwards along the 
crypt-villus axis, while Paneth cells migrate downwards and reside at the very base of 
the crypts (Figure 1, pg 11).  Enterocytes are the most abundant cells in the small 
intestine and function in absorption and breakdown of nutrients.  Goblet cells comprise 
about 8-10 percent of the cells and secrete mucous that creates a barrier between the 
epithelium and the luminal contents.  Enteroendorcrine cells comprise approximately 4 
percent of the intestinal epithelial cells and secrete hormones.  There are many types of 
enteroendocrine cells secreting many different gastrointestinal hormones which regulate 
gastrointestinal (GI) function (Rindi, Leiter, Kopin, Bordi, & Solcia, 2004).  The function 
of Paneth cells is associated with antimicrobial defense.  The average turnover rate of 
small intestinal epithelial cells in mice is approximately three days, except for Paneth 
cells which turnover approximately every 50-60 days {{179 Ireland,H. 2005}}.  On the 
luminal surface, a process of cell shedding into the lumen, called anoikis, occurs, which 
in the healthy intestine is matched by cell renewal in the crypts to maintain constant 
epithelial mass (Gibson, 2004).  These mechanisms of cell proliferation and migration, 
followed by death and shedding into the lumen are essential to maintain the normal 
mass, digestive and absorptive functions of the epithelium.  In the colon a very similar 
renewal and differentiation process occurs except normal colon does not contain 
Paneth cells and cell differentiate as they exit the crypt onto the surface epithelium of 
the colon. 
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Intestinal Epithelial Stem Cells 
The existence of intestinal epithelial stem/multipotent cells (IESC) at the base of 
crypts has been recognized for many years, but their exact identity in not fully defined.  
As early as 1974, proliferating, undifferentiated cells just above and between Paneth 
cells, referred to as crypt-base columnar cells (CBC), were found to give rise to all four 
intestinal epithelial lineages (Cheng & Leblond, 1974).  Other evidence that CBC were 
stem cells came from subsequent studies which found that single mutated cells gave 
rise to all intestinal epithelial cell types within a crypt-villus axis (Bjerknes & Cheng, 
2002), (Winton & Brooks, 1998).  The functional existence of IESC was further 
demonstrated with evidence that clonally proliferating cells appear to regenerate the 
intestinal epithelium after complete depletion of the crypts by exposure to high dose 
irradiation (Potten, 2004).  These IESC near the base of small intestinal crypts have 
been thought to be slowly dividing cells with a cycling time of 24-30 hours compared to 
progenitor or transit amplifying cells higher up in the crypts that have a cycling time 
around 12 hours and have more limited capacity for self renewal (Potten & Loeffler, 
1990), (Bjerknes & Cheng, 2006).  Based on this idea that IESC are slowly dividing, 
label retaining studies that mark slowly dividing cells which retain their template strand 
DNA have been used to predict that out of approximately 250 total cells in each small 
intestinal crypt, only 2 to 6 cells located at cell positions 2-7 from the base of the crypts 
are label retaining cells (LRC), believed to be IESC (Potten & Booth, 1997).  Since a 
majority of LRC were localized at position +4 from the base of the crypt these have 
been termed +4 cells.   
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These studies and characteristics of IESC have led to a concept that there may 
be two populations of IESC, the ‘+4’ IECS lying above Paneth cells and the CBC lying 
between Paneth cells, and exemplifies the fact that there is still a need for conclusive 
evidence to confirm the precise location and identity of IESC.  For example, LRC are 
not solely localized at +4, but are distributed at positions 2-7 from the crypt base, which 
can include the CBC population.  Punitive IESC have also been identified that distinctly 
mark cells in the +4 IESC or CBC zones.  Thus one proposal by Dr. Susan Henning at 
UNC suggests that upper stem cell zone (USZ) and lower stem cell zone (LSZ) may be 
better terminology.  Many aspects of IESC including their location will remain unverified 
until valid IESC markers in the USZ and LSZ are defined.  It is also important to show 
multipotency of these IESC in vitro as well as in vivo for verification that they are true 
IESC.   
IESC Markers 
Recently several IESC markers have been proposed which are preferentially 
expressed in the USZ or LSZ (Figure 1).  Indirect evidence that bone morphogenic 
protein receptor 1a (BMPR1A) and phosphorylated-phosphatase and tensin homolog 
deleted on chromosome 10 (p-PTEN) are markers of IESC in the USZ has been 
demonstrated using label retaining assays and mouse knockout models.  The 
phenotype of BMPR1A and PTEN knockouts showed that deregulation of these 
pathways led to expansion of the IESC zone and an increase in proliferation leading to 
intestinal polyposis (He et al., 2004), (He et al., 2007).  Evidence using microarray 
analysis of small intestinal crypts and short-term label retaining assays indicated that 
Doublecortin- and Calmodulin Kinase-Like 1 (DCAMKL1) may represent another 
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potential IESC marker in the USZ (Giannakis et al., 2006).  The microarray from theses 
same studies identified that Eph receptors could make good candidates for cell surface 
markers of IESC.  This was further strengthened by findings in EphB2 and EphB3 gene 
deletion models which demonstrated a disruption of cell migration and through 
characterization of the expression pattern of Eph receptors (Batlle et al., 2002).  Some 
integrins including α2β1 also make good candidates as surface markers of IESC 
(Beaulieu, 1992).  Musashi-1 shows potential as an IESC marker, since Musashi-1 
positive cells colocalize with label retaining cells and the proliferation marker Ki67 in the 
base of crypts (He et al., 2007; Potten et al., 2003).  However Musashi-1 staining can 
often localize to CBC, +4 cells and also cells at positions higher in the crypt then 
thought to represent IESC.  Strong experimental evidence suggests that Lgr5 is a true 
IESC marker.  Both lineage tracing models and in vitro pluipotency have demonstrated 
that Lgr5 positive cells are CBC cells that give rise to all intestinal cell lineages (Barker, 
van Es, Kuipers, Kujala, van den Born, Cozijnsen, Haegebarth, Korving, Begthel, 
Peters, & Clevers, 2007a; Sato et al., 2009).  Genetic lineage tracing has also been 
used to show that cells expressing Sox9 give rise to all differentiated cell types in the 
embryonic intestine {{155 Akiyama,H. 2005; }}.  Mice that have a Sox9 gene deletion do 
not develop Paneth cells suggest that Sox9 is required for Paneth cell differentiation 
however is not required for the development of the other cell lineages {{156 Mori-
Akiyama,Y. 2007; }}.  Redundancy in function across the Sox protein family is a 
common theme and therefore compensatory effects of other SOX proteins could 
account for differentiation of the other cell lineages in the absence of SOX9 expression 
{{158 Hoser,M. 2008;159 Matsui,T. 2006;  }}.  Endogenous SOX9 protein localizes to 
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the CBC and to cells within the USZ or transit amplifying zones {{157 Blache,P. 2004; }}.  
Recently, Sox9 transcriptional activity was visualized in the intestine using a Sox9EGFP 
reporter mouse.   Differential expression of Sox9EGFP was observed within the USZ and 
LSZ.  Cells expressing high levels of Sox9EGFP (Sox9EGFPHI) where localized to the USZ 
and to cells on the villus.  Further evaluation of these cells revealed that they were post-
mitotic or non-proliferating cells with an enteroendocrine phenotype {{116 
Formeister,E.J. 2009; }}.  Cells expressing low levels of Sox9EGFP (Sox9EGFPLO) localized 
to the LSZ/CBC and these cells were shown to be enriched for Lgr5 and other stem cell 
markers {{116 Formeister,E.J. 2009; }}.  Thus Sox9EGFP may mark terminally 
differentiated enteroendocrine cells in the USZ, as well as LSC/CBC.  A key question is 
whether the non-dividing enteroendocrine cells expressing high levels of Sox9 in the 
USZ may in some instances adopt an IESC phenotype.  Lineage tracing and reporter 
mouse models have shown great potential in identifying IESC, but to date the 
expression pattern of IESC markers has not been fully characterized after injury such as 
irradiation which creates an ideal model to study IESC and their role in regeneration 
after complete crypt loss {{12 Potten,C.S. 2004; }}. 
Irradiation as a model to study IESC 
 Irradiation has been valuable in defining many aspects of cells within the 
intestinal crypts.  This injury model is particularly useful for characterizing IESC and 
their response to injury, because it is a cytotoxic agent that can be precisely controlled 
and measured and can be uniformly delivered across a tissue region or given as whole 
body irradiation.  In the intestine, this model can be used to eliminate proliferative cells 
excluding a few clonogenic cells that are capable of regenerating the intestinal 
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epithelium {{12 Potten,C.S. 2004; }}.  A wide range of doses have been tested and have 
shown that cells within the USZ or +4 zone are highly susceptible to radiation–induced 
apoptosis which peaks at radiation doses as low as 1Gy and is maximal as early as 4 
hours after irradiation.  The highest rate of apoptosis is around position 4 above the 
crypts, but is induced highly throughout the entire crypt base {{144 Potten,C.S. 1998; }}.  
A recent study compared radiosensitivity of USZ or +4 cells and LSZ/CBC and 
suggested that LSZ/CBC cells were more resistant requiring a high dose of 10Gy for 
peak apoptosis (Barker, van Es, Kuipers, Kujala, van den Born, Cozijnsen, Haegebarth, 
Korving, Begthel, Peters, & Clevers, 2007a).  The colon appears to be less sensitive to 
radiation-induced apoptosis at early time points after irradiation and does not show any 
region specific apoptosis along the length of the crypt (Cai, Roberts, Bowley, Hendry, & 
Potten, 1997).  Indeed the identity of colon IESC is less well defined than small intestine 
IESC.  Radiation has also been used to show that IESC in the small intestine have a 
unique ability to protect their genome from mutation {{129 Potten,C.S. 2002; }}.  This, 
along with the high rate of apoptosis in the IESC zone after injury, may present a 
mechanism by which the small intestine prevents proliferation of genetically damaged 
cells and maintains an extremely low rate of cancer formation after genotoxic injury.  
The intestine also seems to be able to effectively recognize the degree of injury 
because it compensates for increases in induced apoptosis at higher dose of irradiation 
by increasing regeneration compared to lower doses (Hendry, Roberts, & Potten, 1992).  
This increase in regeneration as the dose of irradiation is increased suggest that the 
greater the injury, the more cells are recruited into a clonogenic state to help rescue the 
epithelium (Potten, Merritt, Hickman, Hall, & Faranda, 1994).  Clonogenic cells have 
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been considered putative IESC, but irradiation may be altering their phenotype and how 
they compare to IESC before injury has not been established.  Combining a high dose 
irradiation model that shows the greatest increase in clonogenic cells and regeneration, 
with lineage tracing or reporter mouse models could effectively determine any 
differences between IESC before and after irradiation. 
Mediators of regeneration after irradiation 
It is noteworthy that relatively little is known about the local, paracrine or 
autocrine mediators of regeneration after irradiation.  Some studies suggest that 
endothelial cells may be required for appropriate regeneration after irradiation although 
this is controversial (Schuller et al., 2007; Wang, Boerma, Fu, & Hauer-Jensen, 2007).  
Another recent study suggests that the protein, p53 upregulated modulator of apoptosis 
(PUMA), regulates the radiosensitivity of IESC.  PUMA, which works in a p53 
dependent manner, was seen to be highly upregulated in the intestine after irradiation 
and gene deletion of PUMA led to increased regeneration after irradiation.  Interestingly, 
IESC in the USZ appeared to show greater apoptosis then cells in the LSZ (Qiu et al., 
2008).  However, detection and quantification of cells in the LSZ was limited due to the 
difficulty in recognizing these slender cells between more prominent Paneth cells.   
The Sox9EGFP reporter mouse would provide an effective model to visualize these 
cells in the LSZ, as well as to quantify the expression of PUMA on the USZ and LSZ 
and determine the underlying mechanisms regulating PUMA through the isolation of 
Sox9EGFP cells for molecular analysis.  It would be interesting if the increased apoptosis 
of cells in the USZ was associated with Sox9EGFPHI
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identify the importance of these cells in the maintenance of the IESC niche.  This is 
consistent with a previously hypothesized enteroendocrine cell-based quiescent 
intestinal stem cell niche, which has not been confirmed experimentally (Radford & 
Lobachevsky, 2006).   
Therapies for regeneration 
Furthermore, the suppression of PUMA could provide an effective therapy to 
protect IESC from radiation damage.  Insulin-like growth factor-I (IGF-I) suppresses 
PUMA independently of p53 and could be an effective therapy (Han et al., 2001).  IGF-I 
has also been seen to promote SOX9 expression and survival of SOX9 positive cells 
after irradiation (Ramocki et al., 2008).  In other tissues, IGF-I plays a major role in the 
survival, expansion and regeneration of stem cells (Arsenijevic, 2005; Ye & D'Ercole, 
2006).  IGF-I seems to mediate the actions of growth hormone (GH) and GLP2, the only 
approved or under trial trophic therapies for human intestinal disease, respectively 
(Dube, Forse, Bahrami, & Brubaker, 2006; Krysiak, Gdula-Dymek, Bednarska-
Czerwinska, & Okopien, 2007).  However, one complication with using growth factors as 
therapies for cancer patients undergoing radiation therapy is that they are desensitizing 
therapies which may protect not only the normal tissue, but also the tumor tissue 
rendering them ineffective.  Interestingly, GH administered before radiation exposure 
has been seen to protect normal tissue but not implanted adenocarcinoma from 
irradiation.  IGF-I, which is downstream of GH, may be an even more effective therapy, 
but its effects on tumor risk after irradiation should be established (Morante et al., 2003).   
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Crypt microcolony assay 
Irradiation has also been widely used to test therapies that can protect IESC or 
increase regeneration {{15 Potten,C.S. 2003; }}.  Many of these studies utilize the crypt 
microcolony assay, which compares the number of regenerating crypts, as defined by a 
given number of dividing cells, after irradiation in animals with and without treatment 
(Khan, Shui, Ning, & Knox, 1997)(Booth, Booth, Williamson, Demchyshyn, & Potten, 
2004)(Ishizuka et al., 2003).  The crypt microcolony assay is an indirect measurement 
of IESC activity and is often dependent on using a high dose of irradiation that does not 
allow for analysis of the complete regenerative process due to limited animal survival.  
Many of the irradiation models that have been used are limited by either using a low 
dose of irradiation that only eliminates a portion of the IESC population or use of a high 
dose of irradiation that is limited by poor survival of animals.   
Hypothesis 
This study focuses on development of a high dose abdominal irradiation model 
that allows for survival of only IESC that can regenerate the intestine.  It is hypothesized 
that this model will increasing the animal survival rate so that the regenerative response 
of IESC can be further characterized.  This abdominal irradiation model will also used to 
characterize the expression pattern of the putative IESC marker Sox9.  It is further 
hypothesized that Sox9 will provide a useful marker of IESC during the regenerative 
process after irradiation. 
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Figure 1: Intestinal cell lineages and intestinal stem cell (IESC) markers. (A) 
Diagram of an intestinal crypt showing the position of the Upper Stem Cell Zone (USZ) 
in yellow and Lower Stem Cell Zone (LSZ) in light green. (B) Differentiated intestinal cell 
types. (B) Expression pattern of putative IESC markers.  * - These proteins show a 
gradient of expression throughout the IESC zone.  
 
 
 
 
  
Chapter 2 
Methods 
 
Experimental Mice 
 The mice used in these experiments included wild-type C57BL/6 mice and 
Sox9EGFP mice.  The Sox9EGFP mice were provided by Dr. Scott Magness (University of 
North Carolina at Chapel Hill). Sox9EGFP transgenics were originally generated for the 
Gene Expression Nervous System Atlas (GENSAT) BAC Transgenic Project. Frozen 
embryos were obtained from the Mutant Mouse Regional Resource Center and 
reconstituted in foster mice as previously described (Gong et al., 2003) within the 
Mouse Mutant Resource Core at UNC-Chapel Hill.  These mice are on a CD-1 
background and were genotyped by visualization of enhanced green fluorescent protein 
(EGFP) expression in tail snips (Formeister et al., 2009).   
Abdominal irradiation model 
An abdominal irradiation model was developed using the X-RAD 320 irradiator 
from Precision X-Ray (North Branford, CT) that was fitted to simultaneously irradiate up 
to 8 mice.  The mice were anesthetized with 2% isoflurane throughout the procedure.  
The lower half of each mouse below the xiphoid process was placed within a 20cm X 
20cm irradiation zone, while the upper half was kept outside of this area and was not 
exposed to irradiation (Figure 2, pg 17).  The mice were exposed to a total of 14Gy of 
irradiation at a rate of 2Gy/minute.  After irradiation, the mice were housed in an 
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isolation cubicle in room 1131 of the Neuroscience Research Building. This is 
necessary because mice cannot be returned to SPF housing after being removed to 
another facility. 
Tissue Collection 
The mice were killed on days 3, 4, 5, 7 and 9 after irradiation.  Mice were injected 
with 5-ethynyl-2’-deoxyuridine (EdU, Invitrogen A10044, Carlsbad, CA) at a 
concentration of 4µg/g body weight 90 minutes before they were killed. The entire 
intestine was removed and flushed with PBS. Samples were taken from the duodenum, 
jejunum, mid-gut, ileum, and proximal and distal colon for histology or biochemical 
analyses.  Samples for protein or RNA were snap frozen in liquid nitrogen and stored at 
-80ºC.  Samples for histology or immunostaining were fixed for 24 hours in 4% 
paraformaldehyde (PFA) freshly made in PBS.  These samples were then cryo-
protected in 10% sucrose for 24 hours followed by 30% sucrose for 24 hours.  The 
samples were then embedded in Optimal Cutting Temperature (OCT) medium, frozen 
on dry ice and stored at -80ºC.  Tissue sections were cut at 6-10µm thickness and 
placed on positively charged slides for histology or immunostaining. 
Histology and detection of proliferating cells 
To visualize histology, tissue sections were stained with hematoxylin and eosin 
(H&E) by Kirk McNaughton (Cell and Molecular Physiology Department, UNC-Chapel 
Hill).  For immunofluorescence, sections were first washed twice in 0.05 M Tris to for 
three minutes each time remove the OCT.  All washes were done in 0.05 M Tris for 
three minutes each. 
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Proliferating cells were detected based on incorporation of EdU into newly 
synthesized DNA or immunostaining for Ki67. EdU assays use a two-step click reaction 
that is based on detection of incorporated EdU with an Alexa Fluor® azide dye (Alexa 
Fluor® 488) which gives green fluorescence, or Alexa Fluor® 594 which gives red 
fluorescence (Click-iT™ EdU Alexa Fluor® 488 and 594 Imaging Kits, Invitrogen, 
Carlsbad, CA).  EdU contains a small alkyne group that is detected by an azide 
containing fluorescent dye.  EdU offers advantages over commonly used BrdU based 
methods.  Because the Alexa Fluor® dye is small, only mild permeabilization is required 
to detect incorporated nucleotide. No DNA denaturation or antibody-based detection is 
needed which makes the system faster and more compatible with dual labeling for other 
proteins. EdU was detected following manufacturers instructions through steps 3.3 – 4.6 
(see Table 1, pg 18). Ki67 was detected by immunofluorescence as outlined below. 
Immunohistochemistry 
If sections were first stained for EdU, primary antibodies were added directly after 
removal of Alexa fluor dye and the final wach of the Click-iT™ procedure.  If EdU 
staining was not perfomed, the sections were treated with 0.05 M Tris-Triton-X 100 (TT) 
buffer, washed twice, and incubated in 5% Normal Goat Serum in PBS+0.3% Triton-X 
100 (blocking medium) for 30 min at room temperature.  Primary antibodies were added 
to the sections in Dako Antibody Diluent (Dako, S0809, Carpinteria, CA) for 12 hours at 
4ºC at the following dilutions, anti-SOX9 (rabbit, 1:1,000, no. AB5535; Chemicon, 
Temecula, CA), anti-substance P (rat; 1:100, no. MAB356; Chemicon), anti-lysozyme 
(rabbit, 1:1,000, no. RP 028; Diagnostics Biosystems, Pleasanton, CA) and anti-Ki67 
(mouse, 1:100, no. M7249; Dako, Carpinteria, CA).  Detection of Ki67 required antigen 
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retrieval after the initial wash steps by incubating the sections at 125ºC for 30 seconds 
followed by 90ºC for 10 seconds in Reveal Decloaker RTU (no. RV1000MMRTU; 
Biocare Medical, Concord, CA).  These samples were then moved into PBS for 20 
minutes at room temperature.  After primary antibody incubation, sections were washed 
3 times and secondary antibodies were added at the following concentrations, anti-
Rabbit- Alexafluor 488 (1:500, no. Z-25302, Molecular Probes, Eugene, OR), anti-
Rabbit-594 (1:250; no. 711-505-152 Jackson Immunoresearch Laboratories, West 
Grove, PA) and anti-Rat-594 (1:250; no. 712-505-150 Jackson Immunoresearch 
Laboratories, West Grove, PA).  Ki67 required amplification using anit-Mouse IgG-
Biotinylated (1:200; Jackson Immunoresearch Laboratories, West Grove, PA) followed 
by Alexafluor-555-labeled streptavidin (1:250, no. S32355, Molecular Probes).  Sections 
were then washed 3 times and nuclei were stained with Bisbenzamide (1:20000) and 
Draq5 (1:1000 no. BOS-889-001; Biostatus, San Diego, CA) in Tris for 10 min.  This 
was followed by a 5 minute wash and then the slides were cover slipped using 
Hydromount (National Diagnost, no. HS-106, Atlanta, GA). 
A major goal of these studies was to assess if Sox9 marked proliferating cells in 
microcolonies and regenerating crypts between days 3 – 9 after irradiation. Thus the 
localization of immunoreactive Sox9 was compared with Ki67 or EdU on the same 
sections. 
Quantification of Sox9EGFP 
To assess the effects of radiation on regeneration of Sox9EGFP putative stem 
cells, Sox9EGFP was directly visualized at days 3 – 9 after radiation. Prior studies 
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(Formeister 2009) indicate two populations of Sox9EGFP cells defined by high 
expression, Sox9EGFPHI, and low expression, Sox9EGFPLO.  In normal, uninjured small 
intestine, Sox9EGFPHI cells in crypt and villus appear to represent post-mitotic cells 
expressing enteroendocrine markers.  Sox9EGFPLO are localized to the base of the crypts 
at locations thought to represent multipotent stem cells (Formeister 2009). Thus, the 
number of Sox9EGFPHI and Sox9EGFPLO cells was counted in 15 crypts of jejunum on 3 
slides per mouse at days 3, 5, and 9 to assess if there was differential expansion of 
Sox9EGFPHI and Sox9EGFPLO cells during regeneration. In addition, localization of 
Sox9EGFP was compared with immunostaining for substance P (an enteroendocrine 
marker) or lysozyme (a Paneth cell marker) to assess if Sox9EGFP was expressed in 
these differentiatied lineages. 
 
 
 
 
 
 
 
17 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2:  Mouse placement in the X-RAD 320 from Precision X-Ray.  Each mouse 
is kept anesthetized with its head placed in an open syringe connected to a continuous 
tube supplying 2% isoflurane.  The lower half of each mouse is placed within the 
irradiation zone specified by the illuminated area. 
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Permeabilization Remove the wash solution. Add 1 ml 0.5% Triton® 
X-100 in PBS and incubate for 20 minutes at room 
temperature. 
EdU Detection Prepare 1X Click-iT™ EdU buffer additive by 
diluting the 10X solution in deionized water. 
Prepare this solution fresh and use the solution on 
the same day. 
 
Preparation of Click-iT™ reaction cocktail.  Adjust 
to the volume neede  
1X Click-iT™ reaction buff er  – 86uL 
CuSO4                                    –  4uL 
Reaction buff er additive         – 10uL 
Alexa Fluor® azide                 – 0.25uL 
Total Volume                          – 100.25uL 
 
Remove the permeabilization buffer (step 3.3) and 
wash cells twice with 1 mL 3% BSA in PBS. 
Remove the wash solution. 
 Add Click-iT™ reaction cocktail. 
 Incubate for 30 minutes at room temperature, 
protected from light. 
 
Remove the reaction cocktail and wash once with 
1mL 3% BSA in PBS. Remove the wash solution. 
 
Table 1:  Outline of the protocol for EdU detection of proliferating cells. 
 
 
 
 
 
  
Chapter 3 
Results 
Body weight and survival 
 Figures 3A and 3B (pg 27) show body weights and survival rates for CD1 and 
C57BL/6 mice used in this study.  CD1 mice showed 100% survival out to 9 days, the 
latest time point tested to date.  Survival of C57BL/6 mice was slightly less although 
80% of animals survived up to day 7.  To date we have not extensively tested C57BL/6 
mice through the 9 day time point.  Both CD1 and C57BL/6 mice lost weight after 
irradiation.  Peak loss for C57BL/6 mice occurred at day 5 and animals began to regain 
weight by day 7.  After initial weight loss at day 5, CD1 mice maintained body weight 
through day 9.  The high survival rates and increased or maintained body weights of 
C57BL/6 and CD1 mice through days 7 – 9 indicate that the abdominal irradiation model 
will be valuable for assessing crypt regeneration and effects of irradiation on stem cells 
through and beyond day 9. 
Regional effects of abdominal radiation on crypt damage and regeneration 
 Abdominal irradiation of mice at a dose of 14Gy resulted in a differential 
response throughout the small intestine and colon.  Figures 4 – 8 show H&E stained 
sections of duodenum, jejunum, and ileum from non-irradiated mice (Figure 4, pg 28-29) 
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and mice at 3 (Figure 5, pg 30-31), 5 (Figure 6, pg 32-33), 7 (Figure 7, pg 34-35), and 9 
(Figure 8, pg 36-37) days after irradiation.  The duodenum showed the least tissue 
damage and had a regenerative response as early as day 3 after irradiation (Figures 4A 
and 5A, pg 30-33).  This was followed by an increasing hyperplastic response 
characterized by deep, densely staining hyper-regenerative crypts from days 5 through 
9 (Figures 6A, 7A and 8A, pg 32-37).  The duodenum then showed almost complete 
recovery to a normal physiological state, although with some remaining areas of 
regeneration and crypt fission, by day 9 (Figure 8A, pg 36-37).  In the jejunum, there 
was almost complete crypt loss with the appearance of a few small regenerative crypts 
and sub-epithelial microcolonies at day 3 after irradiation (Figure 4B and 5B, pg 28-31).  
There were increasing numbers of hyper-regenerative crypts that continued to expand 
from days 5 through 9 (Figure 6B, 7B and 8B, pg 32-37).  At day 9, there was recovery 
of the villi, but the crypts continued to show a hyperplastic response demonstrated by 
an increase in cell number and size (Figure 8B, pg 36-37).  The ileum showed the 
greatest tissue damage with fewer, shortened villi and almost no crypts at day 3 
(Figures 4C and 5C, pg 28-31).  A regenerative response demonstrated by a recovery 
in the number of villi and hyperplastic crypts was seen at day 5 (Figure 6C, pg 32-33).  
This was followed by the appearance of hyper-regenerative crypts and varying recovery 
of villi at days 7 and 9 after irradiation (Figure 7C and 8C, pg 34-37).   
The subsequent analysis of intestinal stem cells (IESC) in small intestine was 
focused on the jejunum due to the ideal injury response to irradiation characterized by 
crypt loss, proliferating IESC and microcolony formation by day 3, followed by 
regeneration and subsequent hyper-regeneration that has been used in previous 
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studies.  This process is a useful injury and regeneration model for the study of stem 
cells, because the intestinal crypts have been lost due to massive apoptosis and 
regeneration is believed to be mediated by a few multipotent clonogenic stem cells that 
go on to regenerate the intestinal crypts and epithelium (Potten, 2004).    
 Figure 9 (pg 38) shows the response of the proximal and distal colon to 14Gy 
abdominal irradiation.  Neither proximal nor distal colon showed complete crypt loss. 
Crypt damage was evident at days 3 and 5, being more apparent in the distal colon.  In 
both proximal and distal colon there was the appearance of large hyper-regenerative 
crypts by day 7 with adjacent regions showing continued evidence of crypt loss.  
A subset of proliferating cells express SOX9 protein during crypt regeneration 
after irradiation 
 The effects of irradiation on proliferation were analyzed with the markers of 
proliferation Ki67 and EdU.  Ki67 marks actively cycling cells while EdU detects only 
cells in S-phase of the cell cycle.  Expression of SOX9 and Ki67 was compared on the 
same sections to test if SOX9 marks proliferating cells.  In non-irradiated intestine SOX9 
was strongly localized to cells at the crypt base.  Ki67 marked a few of these cells at the 
crypt base and strongly labeled cells higher in the crypts, believed to be progenitor or 
transit amplifying cells.  At day 3 after irradiation, very few Ki67 and SOX9 positive cells 
were localized to sub-epithelial areas, indicative of microcolonies of regenerating stem 
cells.  At days 4 and 5, there was an expansion of Ki67 immunostaining throughout 
regenerative areas and hyper-regenerative crypts (Figure 10, pg 39-40).  The robust 
increase of proliferative cells in hyper-regenerative crypts after high dose irradiation is 
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consistent with previous studies and the hypothesis of increased stem/multipotent cell 
recruitment after high dose irradiation (Hendry et al., 1992).  SOX9 and Ki67 were 
colocalized to a subset of regenerating cells in hyper-regenerating crypts.  There were 
also SOX9 and Ki67 positive cells that did not co-label.  This could be reflective of the 
observation that SOX9 marks non-cycling enteroendocrine cells that would not be 
positive for Ki67 and Ki67 marks transit amplifying cells that are not positive for SOX9.  
 Figures 11 and 12 (pg 41-43) show SOX9 and Ki67 localization in non-irradiated 
colon and colon through days 3 – 7 after irradiation.  In proximal colon of non-irradiated 
mice SOX9 positive cells were located at the base of the crypts.  Most Ki67 cells did not 
overlap with SOX9 although weak Ki67 staining appeared to co-localize with SOX9 in 
some cells at the crypt base.  In hyper-regenerative crypts at days 5 and 7 there was 
clear overlap between some strongly labeled Ki67 cells and SOX9.  At day 3, SOX9 
positive cells at the crypt base did not label with Ki67 while at day 7 hyper-regenerative 
crypts showed clear co-staining for Ki67 and SOX9, although there was not complete 
overlap.  Figure 10 (pg 39-40) shows data for distal colon.  In non-irradiated colon, 
SOX9 was localized to cells at the crypt base and there was clear overlap between a 
subset of these cells and Ki67 staining.  On day 3, Ki67 staining was less obvious. 
However, in hyper-regenerative crypts at days 5 and 7 there was expansion of the 
SOX9 positive cells at the base (day 5) and throughout hyper-regenerative crypts (day 
7) and virtually all of these co-labeled with Ki67.  
To further determine if cells in the jejunum expressing SOX9 were actively 
proliferating, co-immunostaining for SOX9 and EdU were evaluated in jejunum 
(Figure13, pg 44-45).  At day 3 after irradiation, colocalization was seen in 
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microcolonies and sub-epithelial areas.  At later time points, SOX9 colocalized with EdU 
in regenerative areas and hyper-regeneratative crypts (Figure13, pg 44-45).  SOX9 was 
observed to colocalize with only a subset of EdU positive cells.  The subset of co-
staining cells was limited to small microcolonies at day 3 and at the base of the hyper-
regenerating crypts at later time points.  This provides indirect evidence that SOX9 may 
mark early multipotent regenerating stem cells rather than proliferating cells at higher 
locations in the crypt. 
Sox9EGFP expression after irradiation 
The Sox9EGFP reporter mouse was used to further analyze the expression pattern 
of Sox9 after radiation-induced injury and during regeneration.  The Sox9EGFP reporter 
mice breed normally and the EGFP transgene does not cause any negative phenotype 
as described by Formeister (Formeister, 2009). Consistent with findings of Formeister, 
non-irradiated jejunum showed Sox9EGFPLO cells at the crypt base and Sox9EGFPHI cells 
at higher levels in the crypts and on the villi (Figure 14, pg 46). At day 3 after irradiation, 
Sox9EGFP was expressed at the very base of villi and in some sub-epithelial groups of 
cells that may represent microcolonies.  High expressing Sox9EGFP (Sox9EGFPHI) cells 
were identified at day 3, while low expressing Sox9EGFP (Sox9EGFPLO) cells were not 
detectable (Figure 14, pg 46).  Throughout hyper-regenerative crypts at days 5 and 7 
after irradiation, there was a robust expansion of Sox9EGFPLO cells with few Sox9EGFPHI 
cells being detected in most crypts (Figure 14, pg 46).   
Sox9EGFPLO and Sox9EGFPHI cells in the crypts of non-irradiated mice and mice at 
days 3, 5 and 9 after irradiation were counted to assess if there were changes in the 
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number of Sox9EGFP cells in normal crypts compared to regenerative and hyper-
regenerative crypts (Figure 15, pg 47).  Sox9EGFP could not be counted at day 7 due to 
technical reasons.  There were no crypt structures identified at day 3 after irradiation 
and, therefore, the number of Sox9EGFP cells per crypt could not be quantified at that 
time.  Additionally, Sox9EGFPHI cells were present in sub-epithelial areas that could not 
be identified as crypts at day 3.  In regenerative crypts at days 5 and 9 after irradiation, 
no change occurred in the mean number of Sox9EGFPHI cells compared to crypts in non-
irradiated mice.  Sox9EGFPLO cells could not be found at day 3 after irradiation.  At day 5 
after irradiation, the number of Sox9EGFPLO cells increased almost three-fold in hyper-
regenerative crypts.  The number of Sox9EGFPLO cells returned to just above non-
irradiated numbers in crypts at day 9 (Figure 15, pg 47).  The expansion of Sox9EGFPLO 
cells provides indirect evidence that they play an important role in the regenerative 
process. 
It should be noted that while there was not an expansion in the mean number of 
Sox9EGFPHI cells per crypt at days 5 and 9, there was the appearance of occasional 
large crypts with greater numbers of Sox9EGFPHI cells (Figures 16A, pg 48). This 
suggests that local factors within individual crypts during regeneration may dictate the 
regeneration of Sox9EGFPHI cells. 
The cell counting data of Sox9EGFPHI and Sox9EGFPLO should be considered as a 
preliminary qualitative-semi-quantitative test of the patterns of regeneration of 
Sox9EGFPHI and Sox9EGFPLO cells after irradiation.  This reflects the fact that additional 
numbers of animals and samples need to be studied at each time point. The Sox9EGFP 
colony has recently been expanded to permit these additional analyses.  Furthermore, 
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the quantitative data need to be captured from tissue sections prepared soon after 
tissue collection and with samples mounted on the same slide.  This is because there 
was variation in the intensity of Sox9EGFP across slides.  Additionally, given the dramatic 
expansion in Sox9EGFP cells between days 3 and 4, future studies should include 
evaluation of day 4.  It should be noted however that preliminary FACS analysis for GFP 
provides confirmatory evidence that Sox9EGFPLO cells are expanded at day 5 after 
irradiation (Van Landeghem and Magness personal communication).  
Colocalization of Sox9EGFPHI cells and Substance P 
 Sox9EGFPHI cells have previously been shown to be mature/post-mitotic 
enteroendocrine cells, because these Sox9EGFPHI cells colocalized with the 
enteroendocrine cell markers Substance P and Chromogranin-A but not with Ki67 or the 
secretory/enteroendocrine progenitor marker, Neurogenin3 (Formeister et al., 2009).  
Substance P immunostaining was used to determine if Sox9EGFPHI cells exhibit 
enteroendocrine phenotype after irradiation.  At day 3, colocalization of Substance P 
was detected in a majority of Sox9EGFPHI cells (Figure 16, pg 48).  Thus, even in hyper-
regenerative crypts, Sox9EGFPHI cells were immunopositive for an enteroendocrine 
marker.  It will be of interest to compare EdU and Substance P staining in the same 
crypts to assess if these cells are post-mitotic.  Note that Figure 16A shows an example 
of a hyper-regenerative crypt with multiple Sox9EGFPHI and Substance P labeled cells at 
day 5 contrasting with a crypt composed almost solely of Sox9EGFPLO cells at day 7. 
Sox9EGFP and the Paneth cell marker Lysozyme 
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 Previously, two populations of Lysozyme positive Paneth cells have been 
observed that exist at a 1:1 ratio, one with and one without SOX9 protein; however, 
SOX9EGFP is not associated with Lysozyme positive Paneth cells which appear to be 
CBCs between Paneth cells (Formeister et al., 2009).  SOX9EGFP was evaluated after 
Lysozyme immunofluorescence staining to determine if this remained true after 
irradiation.  At day 3 after irradiation, Lysozyme positive cells had lost their normal 
granulated appearance and the staining seemed more diffuse throughout the cytoplasm 
(Figure 17B, pg 49).  This may be because the cells were releasing their lysozyme-
containing granules or because they are apoptotic, which can be further evaluated with 
Caspase-3 staining (Marshman, Ottewell, Potten, & Watson, 2001).  The Lysozyme 
positive cells at day 3 did not colocalize with SOX9EGFP (Figure 17C, pg 49).  At days 5 
and 7 after irradiation, Lysozyme immunostaining returned to a more granulated 
appearance with a few Lysozyme positive cells existing mostly around the base of 
hyper-regenerative crypts (Figure 17B, pg 49).  The majority of Sox9EGFP cells clearly 
did not colocalize with Lysozyme, however colocalization should be evaluated by 
confocal microscopy.  The robust increase in Sox9EGFPLO cells in hyper-regenerative 
crypts at days 7 – 9 was not accompanied by a visual increase in Lysozyme positive 
Paneth cells.  At day 9 after irradiation there was a recovery of more normal appearing 
Lysozyme positive cells at the base of the crypts that appeared largely distinct from 
Sox9EGFPLO or Sox9EGFPHI cells (Figure 17B, pg 49).  Thus, it appears that cells 
expressing Sox9EGFP are distinct from Lysozyme expressing cells.  However, without 
further analysis with confocal microscopy we cannot entirely exclude the possibility that 
some Lysozyme positive cells express Sox9EGFP. 
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Figure 3:  Body weights and survival rates for CD1 and C57BL/6 mice. (A) Survival 
rates of CD1 (blue bars) and C57BL/6 (red bars) after irradiation.  N=7, 5, 3 and 2 for 
CD1 mice and N=11, 9 and 6 for C57BL/6 mice for each day after irradiation 
respectively.  The decrease in n at each time point is the result of experiment use of 
mice at each time point, not death due to injury.  (B) Body weights of CD1 (blue bars) 
and C57BL/6 (red bars) after irradiation.  N=7, 5, 3 and 2 for CD1 mice and N=11, 9 and 
5 for C57BL/6 mice for each day after irradiation respectively.  The standard error of the 
mean is shown. 
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Figure 4: Normal Small Intestinal Physiology.  H&E staining of non-irradiated 
small intestinal photographed at 5X magnification. (A) Duodenum (B) Jejunum (C) 
Ileum  
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Figure 6: Small Intestinal Damage at day 3 after irradiation.  H&E staining 
photographed at 5X magnification. (A) Duodenum with arrow showing regenerative 
crypt (B) Jejunum with arrows to mirocolonies (C) Ileum showing villi and crypt loss 
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Figure 6: Regenerative response in the small intestine at day 5 after irradiation.   
H&E staining photographed at 5X magnification. Arrows point to regenerative 
crypts (A) Duodenum (B) Jejunum with recovery of crypts (C) Ileum showing recovery 
of villi and crypts 
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Figure 7: Hyper regenerative response at day 7 after irradiation.  H&E staining 
photographed at 5X magnification. Arrows show examples of hyper-regenerative 
crypts that have an increase in size and cell density (A) Duodenum with an increase 
in the number of hyper-regenerative crypts (B) Jejunum with increasing regenerative 
crypts (C) Ileum with hyper-regenerative crypts and disorganized recovery to irradiation 
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Figure 8: Increase in regeneration and crypt fission at day 9 after irradiation.  H&E 
staining photographed at 5X magnification. Arrows show areas of crypt fission in 
the duodenum and jejunum as well as regeneration in the ileum. (A) Duodenum (B) 
Jejunum (C) Ileum  
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Figure 9: Colon has shorted crypts followed by areas of regeneration after 
irradiation.  H&E staining photographed at 4X and 10X magnification.. Arrows 
show areas of regeneration.  (A) Proximal colon at 4x. (B) Proximal colon at 10x. (C) 
Distal colon at 4X. (D) Distal colon at 10X. 
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Figure 10:  SOX9 protein and Ki67 colocalize in microcolonies and hyper-
regenerative areas after irradiation. (A) H&E staining at higher magnification in areas 
representative of immunofluorescence staining. (B) SOX9 protein (SOX9) in green. (C) 
Ki67 staining in red. (B) SOX9 protein (SOX9) staining in green shows colocalization 
with Ki67 in red. (C) Nuclear staining in blue. 
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Figure 11: SOX9 protein and Ki67 colocalize in crypts of proximal colon. (A) H&E 
staining at higher magnification in areas representative of immunofluorescence staining. 
(B) SOX9 protein (SOX9) in green. (C) Ki67 staining in red. (B) SOX9 protein (SOX9) 
staining in green shows colocalization with Ki67 in red. (C) Nuclear staining in blue. 
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Figure 12: SOX9 protein and Ki67 colocalization in crypts of distal colon. (A) H&E 
staining at higher magnification in areas representative of immunofluorescence staining. 
(B) SOX9 protein (SOX9) in green. (C) Ki67 staining in red. (B) SOX9 protein (SOX9) 
staining in green shows colocalization with Ki67 in red. (C) Nuclear staining in blue. 
 
 
 
 
 
 
 
 
 
 
 
 
 
44 
 
 
 
45 
 
Figure 13: SOX9 protein colocalizes with a subset of EdU positive cells in sub-
epithelial areas and at the base of hyper-regenerative crypts. (A) SOX9 protein 
(SOX9) staining in green. (B) EdU staining in red (C) Overlay of SOX9 and EdU 
showing colocalization in sub-epithelial areas at day 3 and at the base of hyper-
regenerative crypts at days 4 and 5. (D) Nuclear staining in blue corresponding to the 
pictures above. 
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Figure 14: Sox9EGFPLO cells are lost at day 3 and then show vast expansion in 
hyper-regenerative crypts at days 5 and 7 after irradiation. (A) H&E staining of 
areas representative of the immunofluorescence staining in B and C. (B) Distribution of 
Sox9EGFPHI and Sox9EGFPLO cells after irradiation. (C) Overlay of Sox9EGFP and nuclear 
stain in blue. 
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Figure 15: There is no change in the number of Sox9EGFPHI cells after irradiation, 
while Sox9EGFPLO cells increase almost 3 fold.   Quantification of Sox9EGFPHI (     ) 
and Sox9EGFPLO cells (     ). (A) Sox9EGFPexpression.  (B) Corresponding nuclear 
staing.  (C) Sox9EGFP cells were counted in 15 crypts from 1 animal at each time point.  
There is no change in the number of Sox9EGFPHI cells at any time point, while 
Sox9EGFPLO cells showed a 2.93 fold change (6.47±0.413 vs. 19±1.919) in hyper-
regenerative crypts at day 5 after irradiation.  The standard error of the mean is shown. 
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Figure 16: Sox9EGFPHI cells colocalize with most Substance P expressing cells 
after irradiation. (A) Distribution of Sox9EGFPHI and Sox9EGFPLO cells after irradiation. 
(B) Immunostaining for Substance P (Sub P) in red. (C) Overlay of Sox9EGFP and 
Substance P show colocalization of almost all Sox9EGFPHI cells and Substance P. (D) 
Nuclear staining in blue corresponding to the pictures above. 
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Figure 17:  Lysozyme positive Paneth cells did not colocalize with Sox9EGFP cells 
and did not show an increase at any time point after irradiation. (A) Sox9EGFP 
shows a loss, followed by a dramatic increase in Sox9EGFPLO cells with no change in 
Sox9EGFPHI cells. (B) Lysozyme staining becomes blurred at day 3 and returns to a 
granular state at later time points.  There does not appear to be an increase in 
Lysozyme positive cells an any time point. (C) Overlay of Sox9EGFP and Lysozyme 
immunofluorescent staining showing no colocalization. (D) Nuclear staining in blue 
corresponding to the pictures above.
  
 
Chapter 4 
Discussion 
 Whole body irradiation provides a useful experimental model, but has the 
potential disadvantage that a majority of WT animals die between 5 and 7 days after 
irradiation precluding analyses of complete crypt and villus regeneration (Qui 
2008)(Potten, 2004).  With this in mind, we adapted an abdominal irradiation model for 
our studies with the goal of improve animal survival beyond 5 – 7 days.  In addition, 
abdominal irradiation may better mimic radiation-induced damage that occurs clinically 
due to regional radiation for abdominal malignancy (Kountouras, Zavos 2008).  Our 
study using abdominal irradiation revealed that a majority of animals survived up to 7 – 
9 days and began to gain or maintain weight.  This suggests that the model will prove 
valuable for evaluating later time points in future studies.  This model was then used to 
evaluate the expression pattern of the putative IESC marker, Sox9. 
 Irradiation has been widely used as a model to study crypt loss and regeneration 
(Potter 2004, Qui, Carson-Walter 2008).  Extensive studies by Potten and colleagues 
have used different doses of whole body γ-irradiation to assess susceptibility of small or 
large bowel crypts to radiation-induced apoptosis.  These analyses indicate that small 
intestinal crypts showed higher levels of early apoptosis at 4 – 6 hours after irradiation 
(the time of peak apoptosis response) compared with colon (Potten 2004).  Radiation 
models have also been used to study crypt regeneration after radiation and most 
51 
 
studies have focused on days 3 through 5 after irradiation when colonies of proliferating 
cells or expanded crypts with proliferating cells are believed to reflect clonal expansion 
of intestinal stem cells surviving the injury (George 2009, Qiu 2008).  However, 
relatively few published studies have evaluated crypt loss and regeneration after 
abdominal radiation along the entire length of small and large intestine in the same 
animals after irradiation (Freeman 2001).  Our studies revealed clear regional 
differences in crypt loss after abdominal radiation.  In the small intestine, the duodenum 
was most resistant to radiation-induced crypt loss with crypts remaining at all times 
studied, but regenerative responses still occurring by days 7 and 9.  Jejunum and ileum 
exhibited complete crypt loss by days 3 and 5 with ileum showing significantly greater 
damage.  The differential response to irradiation defined here by increasing injury from 
the proximal to the distal end of the small intestine may be reflective of differences in 
stem cell properties within each region.  In the duodenum, there may be more IESC, 
these IESC may be less sensitive or have greater regenerative capacity in response to 
irradiation.  In this regard it is noteworthy that one recently defined stem cell marker 
Bmi1 appears to be selectively expressed in proximal small intestine suggesting 
differences in stem cell populations throughout the intestine (Sangiorgi & Capecchi, 
2008).  Future studies to better understand the mechanisms that allow duodenal stem 
cells to survive and regenerate will be relevant to strategies that may increase 
regeneration in other areas of the intestine.   
Consistent with prior findings by Potten that colon crypt cells show lower rates of 
irradiation induced apoptosis than the small intestine, our findings suggest that the 
colon was more resistant to crypt loss after 14Gy abdominal body irradiation than small 
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intestine.  Neither proximal nor distal colon showed complete crypt loss at days 3 and 5. 
Furthermore, it has been observed that germ-free mice are less susceptible to radiation 
induced crypt damage (Crawford & Gordon, 2005).  Despite this, by day 7 there was a 
marked increase in regenerating crypts, occurring with the appearance of inflammatory 
infiltrates.  While more needs to be done to verify inflammation, such as staining for 
immune cells, this observation may reflect that damage in the colon after irradiation may 
lead to barrier defects that expose the underlying lamina propria to high levels of luminal 
microbiota that initiate an inflammatory response.  This inflammatory response may be 
aiding regeneration after irradiation.  We also speculate that the greater damage to the 
ileum compared to more proximal regions of the small intestine could also reflective of a 
difference in the inflammatory response and microbiota.  Comparisons of crypt loss and 
regeneration across the small intestine and colon may be useful in understanding the 
role of inflammation during regeneration after irradiation in a setting of different degrees 
of damage-induced inflammation.   
 Biomarkers of IESC in different regions of the intestine would allow for better 
understanding of their responses to radiation.  Based on recent evidence that Sox9 
marks stem cells, our studies analyzed whether Sox9 marked regenerating crypts after 
radiation (Formeister et al., 2009).  Co-localization of Sox9 and Ki67 immunostaining 
suggests that Sox9 does mark a subset of proliferating cells in jejunal microcolonies and 
colonic crypts at day 3 after radiation and marks even more cells in hyper-regenerating 
crypts later after radiation.  This provides strong evidence that Sox9 is a biomarker for 
regenerating crypt stem or progenitors after radiation, as well as in normal small 
intestine.  
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The expression pattern and molecular properties of Sox9 positive cells was 
further evaluated using a Sox9EGFP reporter and it has been reported that Sox9EGFPLO 
cells are crypt base columnar (CBC) with stem cell like properties during a normal 
physiological state (Formeister et al., 2009).  In this study we used a model of high dose 
irradiation to test if Sox9EGFP expression is useful for identifying IESC after injury.  
Results show that Sox9EGFPLO cells appear to be eliminated at day 3 after high dose 
irradiation when clonogenic IESC are present.  The loss or reduction of Sox9EGFPLO 
cells, that are hypothesized to be IESC, emphasized the dynamic nature of IESC after 
injury and the regenerative process.   
One interesting observation was that Sox9EGFPHI cells are still visible at day 3 
after high dose irradiation, many of which colocalize with Substance P.  Further 
characterization of these cells with other markers such as Neuorgenin 3 is needed, but 
it remains a possibility that these Sox9EGFPHI cells revert back to a stem cell like 
phenotype after injury, a phenomenon that has been identified in other tissues 
(Harrisingh et al., 2004; Zhang et al., 2009).  In this scenario, the proliferating cells 
undergoing mitosis that are more susceptible to mutation during injury would undergo 
apoptosis, while a less susceptible quiescent progenitor or differentiated cell would 
avoid mutation and revert back to a stem cell after injury.  This dedifferentiation of a 
Sox9EGFPHI enteroendocrine cell into a stem cell could represent a mechanism by which 
the small intestine avoids proliferation of cells with DNA damage or mutation and could 
explain the absence of Sox9EGFPLO cells.  However, at this point more needs to be done 
to assess if Sox9EGFPHI cells after irradiation do revert to proliferative cells. 
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It is also possible that upon injury, Substance P expressing Sox9EGFPHI cells 
enhance the survival of surrounding quiescent IESC that are not initially identified by 
Sox9EGFP expression and have an ability to protect their original genome (Potten, Owen, 
& Booth, 2002).  The close proximity of quiescent stem cells and Sox9EGFPHI cells, both 
located in the upper stem cell zone, makes it plausible that there may be interactions 
between these cells.  However, the location of quiescent IESC at position 4 above the 
base of the crypt is the cellular site of greatest frequency of apoptosis after irradiation 
(Wilkins et al., 2002).  Therefore, quiescent IESC may not be the best candidate for 
regenerative IESC.  In this case, Sox9EGFPHI cells may influence surrounding cells to 
adapt a stem cell-like phenotype.  There is evidence that Substance P increases 
regeneration after irradiation (Kang, Kim, Yi, & Son, 2009).  The release of Substance P 
from Sox9EGFPHI cells could conceivably provide a paracrine mechanism driving the 
increase in proliferation and regeneration of adjacent IESC.  At present this possibility is 
speculative, but could be tested by Substance P neutralization or administration.  The 
stimulation by Substance P of surrounding cells could lead them to a phenotype more 
like CBC that could then be identified as Sox9EGFPLO cells at later time points after 
irradiation.  This would account for the vast increase in Sox9EGFPLO cells in hyper-
regenerative crypts at later time points after irradiation.   
The increase in Sox9EGFPLO cells in hyper-regenerative crypts after irradiation is 
not accompanied by an increase in Paneth cells, which have been seen to decrease 
after irradiation (Brennan, Carr, Seed, & McCullough, 1998).  The increase in 
Sox9EGFPLO cells does occur in conjunction with an increase in proliferation in hyper-
regenerative crypts suggesting that these Sox9EGFPLO cells may be acting as progenitor 
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or stem cells.  An interaction between Sox9EGFPHI and Sox9EGFPLO cells is supported by 
the observation that some hyper-regenerative crypts marked with an extensive number 
of Sox9EGFPLO cells also have Sox9EGFPHI cells often times at almost regular intervals 
between the Sox9EGFPLO cells.  This interaction may be unique to regeneration and the 
presence of Sox9EGFPHI cells in the upper stem cell region of only some crypts during a 
normal physiological state could be a protective mechanism for situations when an 
increase in regeneration is needed, such as after injury.  Further understanding of the 
unique expression pattern and molecular characteristic of Sox9EGFP cells after injury 
could help us to define the IESC phenotype and niche driving the regenerative process. 
This study would be greatly enhanced with further evaluation of current samples 
and more animals using confocal microscopy.  In this regard, I recently completed 
additional experiments to increase the sample size to at least four animals per time 
point at 3 – 9 days after irradiation.  Ongoing analyses of these samples and detailed 
characterization of EdU colocalization with IESC biomarkers or markers of differentiated 
cells will provide important information to optimally design future growth factor 
interventions.  We also have begun fluorescent-activated cell sorting (FACS) analysis to 
quantitatively assess the relative proportions of Sox9EGFPHI and Sox9EGFPLO cells at 
different times after irradiation.  This could confirm the absence of Sox9EGFPLO cells at 
day 3 after irradiation as the regenerative process may only require a few surviving 
stem cells and the identification of Sox9EGFPLO cells at day 3 after irradiation by 
histological analysis alone may not be sufficient.  Quantification through FACS analysis 
may also confirm of the expansion of Sox9EGFPLO during regeneration.   
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FACS sorting can also be used to isolate Sox9EGFP cells for microarray analysis.  
Comparing the molecular phenotype of Sox9EGFP cells from non-irradiated mice with 
cells from mice at different time points after irradiated could identify genes that are 
important in stimulating regeneration.  These genes will be relevant to developing 
therapies to promote IESC regeneration in patients exposed to irradiation.  It would also 
determine the molecular differences between steady-state IESC and IESC post-
irradiation.  Understanding these differences is important, because as this study 
exemplifies there are major dramatic differences in Sox9 cells during steady-state 
regeneration and during the regenerative process stimulated by injury.  
Sox9EGFP cells isolated by FACS can also be used for in vitro studies.  One in 
vitro study that would test the dedifferentiation of Sox9EGFPHI cells into IESC could be 
done by isolating Sox9EGFPHI cells from normal intestinal tissue, exposing them to high-
dose irradiation and maintaining them in culture to determine if they dedifferentiate.  
Sox9EGFPLO cells could also be isolated and treated with Substance P to determine if 
Substance P increases proliferation.   
This study focused on proliferation during the regenerative process after high 
dose irradiation, but this abdominal irradiation model in conjunction with stem cell 
markers can also be used to determine the radiosensitivity of different IESC populations 
at different doses of irradiation.  The highest rate of apoptosis occurs around 4 hours at 
position +4 in the USZ after low dose irradiation, but there is apoptosis at all positions 
(Potten & Grant, 1998) (Potten, 1992).  Recent work demonstrated that maximum 
apoptosis in the USZ is reached at 1Gy, while maximum apoptosis of CBC cells in LSZ 
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is reached at 10Gy (Barker, van Es, Kuipers, Kujala, van den Born, Cozijnsen, 
Haegebarth, Korving, Begthel, Peters, & Clevers, 2007b).  Therefore the expression 
pattern of Sox9EGFP should be evaluated at 4 hours after irradiation at both high and low 
doses of irradiation to determine the relative radiosensitivity of Sox9EGFPHI cells in the 
USZ and Sox9EGFPLO cells in the LSZ. 
This irradiation model can also be used for preclinical testing of potential 
therapies for patients undergoing abdominal radiation therapy.  It is estimated that 60-
80% of cancer patients that undergo radiation therapy show signs of acute bowel 
toxicity which include diarrhea, abdominal pain and nausea.  Delayed bowel toxicity is 
characterized by malabsorption and bowel dysmotility (Hauer-Jensen, Wang, Boerma, 
Fu, & Denham, 2007).  Multiple growth factors have been investigated for their 
therapeutical properties, but this has been based on their ability to increase the number 
of microcolonies at early time points after in high-dose irradiation (Potten et al., 1995).  
The use of this abdominal irradiation model with Sox9EGFP reporter mice, other reporter 
mice or lineage tracing models can directly test the expansion and differentiation of 
stem cells throughout the regenerative process.   
Insulin-like growth factor I (IGF-I) has potential as a therapy for abdominal 
irradiation patients.  IGF-I transgenic mice have enhanced intestinal growth and show 
increase proliferation in crypts (Ohneda, Ulshen, Fuller, D'Ercole, & Lund, 1997).  It has 
also been shown that IGF-I decreases apoptosis in crypts at 4 hours after 5Gy of 
irradiation, having the greatest affect in the USZ (Wilkins et al., 2002).  Furthermore, 
IGF-I can suppress PUMA, a p53 dependent protein, that has been seen to increase the 
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radiosensitivity of cells in the IESC zone after irradiation (Han et al., 2001; Qiu et al., 
2008).  The model of abdominal irradiation developed in this study can be used to 
determine if IGF-I treatment protects Sox9EGFP cells from apoptosis.  It will be interesting 
to diescover if IGF-I protects Sox9EGFPHI cells at low doses of irradiation, while protecting 
Sox9EGFPLO cells at high doses of irradiation, and to observe any difference in the 
regenerative process.   
The abdominal irradiation model developed in this study provides a useful model 
for studying IESC and regeneration.  This model resulted in increased survival 
compared to previously models used in other studies.  This will allow for better analysis 
of regeneration after irradiation and the role of IESC during this process.  It was 
observed in this study that Sox9 marked proliferating cells in microcolonies and 
regenerative areas.  It was also seen that Sox9EGFPLO cells, which could not be identified 
with immunostaining with differentiated cell markers, were greatly expanded throughout 
regenerative crypts.  Together this suggests that Sox9 is a useful marker of IESC after 
irradiation.  Future studies using this model can test other IESC markers, including 
LGR5 and Bmi1, to understand how they react to irradiation.  This could give us insight 
into whether there are different IESC populations that have varying responses to injury.  
Finally, future studies can test therapies that may have the potential to help cancer 
patients undergoing radiation therapy and define the effects of growth factors on cell 
phenotype.  Evidence suggests that IGF-I could be an effective therapy for patients 
undergoing radiation therapy.  Our laboratory plans to assess IGF-I in the Sox9EGFP 
irradiation model and to cross Sox9EGFP and another stem cell reporter mouse, Lgr5-
LacZ mice, with the IGF-I transgenic mice to further define the role of IGF-I in stem cell 
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proliferation, expansion or regeneration in normal or irradiated intestine.  This radiation 
model will allow us to gain greater knowledge of IESC and therapies that can increase 
their survival and regeneration to help people exposed to irradiation. 
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Appendix 1 
Biochomoendoscopy and Ileo-cecal resection of CONV-IL-10 null mice 
 The focus of my independent research project on the irradiation model is 
presented in the main thesis.  I also participated in two other studies aimed at improved 
visualization of gastrointestinal tumors using molecular probes and development of an 
ileo-cecal resection model in IL-10 null mice, as a model to analyze stem cells during 
post-surgical adaptive growth of small intestine in a setting of inflammation.  Co-
authorship on two publications resulted from my participation in these projects as listed 
below: 
Zhang H, Morgan D, Cecil G, Burkholder A, Ramocki N, Scull B, Lund PK. 
 Biochromoendoscopy: molecular imaging with capsule endoscopy for detection of 
 polypoid lesions in the GI tract. Gastrointestinal Endoscopy 2008; 68(3):520-7. 
 PMID: 18499106. 
Rigby RJ, Hunt MR, Scull BP, Helmrath MA, Lund PK. A new animal model of post-
surgical inflammatory bowel disease and fibrosis: the effect of commensal 
microflora. Gut 2009. PMID: 19398439. In Press. 
The abstract from these publications are provided as appendix material. 
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Appendix 2 
Biochromoendoscopy: molecular imaging with capsule endoscopy for 
detection of polypoid lesions in the GI tract. 
BACKGROUND: Current capsule endoscopy (CE) provides minimally invasive 
technology for GI imaging but has limited ability to diescriminate different types of 
polyps. Near infrared fluorescent (NIRF) probes activated by biomarkers upregulated in 
adenomas (eg, cathepsin B) are potentially powerful tools to distinguish premalignant or 
malignant lesions from benign or inflammatory lesions. OBJECTIVES: To examine 
whether CE can be integrated with NIRF probes to detect adenomas and whether 
cathepsin B-activated NIRF probes are activated by benign or inflammatory lesions. 
DESIGN: Mouse models of adenomas, hyperplactic/lymphoid polyps, and acute or 
chronic intestinal inflammation were injected intravenously with a cathepsin B-activated 
probe (Prosense 680). Dissected intestine was imaged with CE under white or NIRF 
light. For NIRF excitation (680 nm), dichroic and emission (700 nm) filters were 
combined with CE when images were recorded. Prosense 680 samples with or without 
protease were used as positive and negative controls. CE-based imaging data were 
verified by using and independent imaging system (Xenogen IVIS system). MAIN 
OUTCOME MEASUREMENTS: Proof of principal that CE integrated with NIRF probes 
can detect and diescriminate adenomas from other lesions. RESULTS: CE-based NIRF 
imaging with Prosense 680 readily visualized adenomas, including in the colitis model. 
NIRF signals of different intensities were detected. Prosense 680 was not activated by 
benign or inflammatory lesions. LIMITATION: Optical filters external to the capsule were 
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used. CONCLUSIONS: We demonstrate proof of the principle that 
biochromoendoscopy-CE combined with molecular probes--provides a novel approach 
that differentiates adenomas from benign polyps and inflammatory lesions. 
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Appendix 3 
A new animal model of post-surgical inflammatory bowel disease and 
fibrosis: the effect of commensal microflora. 
OBJECTIVE: Ileo-cecal resection (ICR) is common in Crohn's disease (CD). 
Inflammation and fibrosis frequently recur at the site of anastomosis or in the small 
intestine (SI). No animal models of post-surgical inflammation and fibrosis exist. We 
developed a model of ICR in IL-10 null and wild-type (WT) mice to test the hypothesis 
that that ICR promotes post-surgical inflammation and fibrosis in SI or anastomosis of 
genetically susceptible IL-10 null, but not WT or germ free (GF)-IL-10 null mice. 
DESIGN: GF-IL-10 null mice were conventionalized (CONV) and 3 weeks later 
randomized to ICR, transection (T) or no treatment (NoTx). Age-matched conventionally 
raised (CONV) WT and GF-IL-10 null mice received ICR, T or NoTx. Animals were 
killed 28 days later. MAIN OUTCOME MEASURES: Histological scoring, real-time PCR 
for TNFalpha and collagen, and immunostaining for CD3+ T cells, assessed 
inflammation and fibrosis. RESULTS: After ICR, CONV-IL-10 null, but not CONV-WT 
mice, developed significant inflammation and fibrosis in SI and inflammation in 
anastomosis compared to NoTx or T controls. Fibrosis occurred in anastomosis of both 
CONV-IL-10 null and CONV-WT following ICR. GF-IL-10 null mice developed little or no 
inflammation or fibrosis in SI or anastomosis after ICR. CONCLUSIONS: ICR in CONV-
IL-10 null mice provides a new animal model of post-surgical inflammation and fibrosis 
in SI and anastomosis. Absence of inflammation and fibrosis in SI of CONV-WT and 
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GF-IL-10 null following ICR indicates that post-surgical small bowel disease occurs only 
in genetically susceptible IL-10 null mice and is bacteria dependent. 
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